Lenalidomide shows promise for treating ATLLFebruary 3, 2016Lymphoma & Plasma Cell DisordersNon-Hodgkin Lymphoma
Study suggests chidamide could treat rel/ref CTCL tooFebruary 2, 2016Lymphoma & Plasma Cell DisordersNon-Hodgkin Lymphoma
NICE issues draft guideline for NHLFebruary 1, 2016Lymphoma & Plasma Cell DisordersNon-Hodgkin Lymphoma
New insight into CLL developmentJanuary 25, 2016Leukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersNon-Hodgkin Lymphoma
Drug granted another breakthrough designation for CLLJanuary 21, 2016Leukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersPharmacyNon-Hodgkin Lymphoma
FDA approves maintenance therapy for CLLJanuary 20, 2016Leukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersPharmacyNon-Hodgkin Lymphoma
Drug gets priority review as CLL treatmentJanuary 13, 2016Leukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersPharmacyNon-Hodgkin Lymphoma
Increasing eligibility for engineered T-cell therapyJanuary 8, 2016Leukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersPediatricsALLNon-Hodgkin Lymphoma
How microbes drive progression of CTCLJanuary 7, 2016Lymphoma & Plasma Cell DisordersNon-Hodgkin Lymphoma
Novel delivery system could treat MCLJanuary 6, 2016Lymphoma & Plasma Cell DisordersNon-Hodgkin Lymphoma
Mutations could be therapeutic target for FLJanuary 5, 2016Lymphoma & Plasma Cell DisordersNon-Hodgkin Lymphoma
EZH2 inhibitor can produce durable responsesDecember 31, 2015Lymphoma & Plasma Cell DisordersNon-Hodgkin Lymphoma
Antibody shows promise for treating CLLDecember 22, 2015Leukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersNon-Hodgkin Lymphoma
Venetoclax produces deep responses in ultra-high-risk CLLDecember 17, 2015Leukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersNon-Hodgkin Lymphoma
Surprising finding in upfront use of idelalisib monotherapyDecember 15, 2015Leukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersNon-Hodgkin Lymphoma